Brazil’s new process for examining pharma patents faces scepticism

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Brazil’s new process for examining pharma patents faces scepticism

June 07, 2017
brazil-flag.png

A new procedure for approving pharmaceutical patents in Brazil comes into effect on June 12 with the aim of ending the arduous double examination by the BPTO and Anvisa. Uncertainties such as whether the national health agency will be happy to be overruled by BPTO will need to be resolved to overcome doubts, however

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

BrazilNewsPatentsLatin America and CaribbeanJurisdictions
more from across site and ros bottom lb

More from across our site

Patents
PONTYPRIDD, MID GLAMORGAN, WALES, UK - SEPTEMBER 25, 2024: THATCHERS CIDER ALCHOHOLIC DRINKS ON DISPLAY
This week on MIP: UK proposes AI opt-out | Cider trademark row
A UK government consultation on AI and copyright, a patent blow for Lenovo and a trademark row over cider were among the big talking points this week
Max Walters, December 20, 2024
Patents
New year 2024.jpg
Editor’s picks: top Managing IP stories of 2024
Our most popular stories of the year included a rundown of the 50 most influential people in IP, our in-house ones to watch, and UPC news
Max Walters, December 20, 2024
Awards
Copy of EMEA awards 2024-Shortlist Announced-1200x627.png
LMG Life Sciences Awards EMEA 2025: open for entries
It is time to submit nominations for the sixth annual Life Sciences Awards EMEA
James Wilson, December 19, 2024
Trade Secrets
Photo_Keejeong KIM - #3680325v1_AD_.jpg
Bigger and better: why former Yulchon partner returned home
Keejeong Kim, who returned to Yulchon after a four-year gap, said he was intrigued by the opportunity to work on neighbouring areas of law to IP
Sukanya Sarkar, December 19, 2024
Patents
investment.jpg
Lumenci eyes accelerated growth with private equity investment
The IP consulting firm hopes to expand its services and outreach with the support of investors VSS Capital Partners and Century Equity Partners
Sukanya Sarkar, December 19, 2024
Patents
Dexcom headquarters building exterior. DexCom, Inc. develops, manufactures, and distributes glucose monitoring systems for diabetes management. - San Diego, California, USA - 2020
UPC latest: CoA decision has retroactive effect | Dexcom defeat | 2025 predictions
This update includes a ruling from the Court of Appeal, a judgment of the Paris Local Division, news of upcoming hearings, and predictions for 2025
James Nurton, December 19, 2024
Copyright
Generative AI.jpeg
2024 review: counsel plagued by AI uncertainty and copyright questions
US counsel review the key copyright and trademark trends of 2024, including generative AI disputes and SCOTUS cases
Rani Mehta, December 18, 2024
Patents
Silhouette of business man following his ambitions, Generative Ai illustration
Weekly take: Consolidation and IP transactions in firms’ 2025 sights
If 2024 is anything to go by, the next 12 months could see more IP firms seek investment opportunities while IP lawyers are increasingly likely to work alongside other functions
Max Walters, December 18, 2024
Patents
2024-comp.jpg
2024 review: US counsel reflect on top patent trends
Practitioners reflect on the impact of USPTO guidance, as well as PTAB and litigation trends
Rani Mehta, December 18, 2024
Patents
MIP Podcast newsletter header banner sample-2000.jpg
The IP Lounge: Top 50 people in IP | social media habits
We discuss Managing IP’s 50 most influential people in IP list and look back on the biggest talking points in the last month
Max Walters, December 16, 2024
Gift this article